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Abstract
Purpose—There is substantial variation across the National Breast and Cervical Cancer Early 
Detection Program (NBCCEDP) grantees in terms of the proportion of the eligible population 
served by the grantees each year (hereafter referred to as the screening proportion). In this paper, 
we assess program- and state-level factors to better understand the reason for this variation in 
breast and cervical cancer screening proportions across the NBCCEDP grantees.
Methods—We constructed a longitudinal data set, consisting of data from NBCCEDP grantees 
for each of the three study years (program-years 2006–2007, 2008–2009, and 2009–2010). We 
performed multivariate analysis to explain the variation in breast and cervical cancer screening 
proportions across the grantees. The program-level factors studied were the total federal funds 
received, average cost of screening women by grantee, and the overall organizational structure. 
The state-level variables included were urban versus rural mix, access to care, and the size of the 
eligible population.
Results—Of the 48 grantees included in the study, those that serve larger populations, as 
measured by the size of the population and the percentage of women eligible for services, had 
lower screening proportions. Higher average cost of service delivery was also associated with 
lower screening proportions. In addition, grantees whose populations were more concentrated in 
urban areas had lower screening proportions.
Conclusions—Overall, the average cost of screening, the overall size of the population eligible, 
and the concentration of population in urban areas all had a negative relationship to the proportion 
of eligible women screened by NBCCEDP grantees.
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The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) was 
established by Congress in 1990 to provide low-income, uninsured, and underserved women 
access to timely breast and cervical cancer screening and diagnostic services. The 
NBCCEDP is administered by the Centers for Disease Control and Prevention (CDC), and 
the key goal of the NBCCEDP is to improve outcomes for low-income women by 
identifying breast and cervical cancers at an early stage when treatments are most effective. 
With the passage of the Breast and Cervical Cancer Prevention and Treatment Act in 2000, 
the overall goals of the NBCCEDP were further strengthened. Women diagnosed with 
cancers through the NBCCEDP became eligible to obtain treatment services through state 
Medicaid programs [1].
The NBCCEDP provides direct services to uninsured and underinsured women with 
incomes at or below 250 % of federal poverty level. Women aged 18–64 receive cervical 
cancer screening (the age of eligibility was increased to 21 years in 2012 to align with 
updated clinical recommendations), and women aged 40–64 receive breast cancer screening 
[2–4]. About 11 % of US women were eligible for NBCCEDP cervical cancer screening and 
about 10 % for breast cancer screening [5, 6]. Since 1991, the NBCCEDP-funded programs 
in the states, District of Colombia (DC), territories, and tribes have screened more than 4.6 
million women, provided more than 11.6 million breast and cervical cancer screening 
examinations, and diagnosed more than 64,718 breast cancers, 3,576 invasive cervical 
cancers, and 167,169 premalignant cervical lesions, of which 40 % were high grade (http://
www.cdc.gov/cancer/nbccedp/about.htm).
The proportion of the eligible population screened by the grantees has been historically low. 
Based on NBCCEDP data from selected years during the period from 2010 to 2012, it is 
estimated that the NBCCEDP screened on average 10.6 % of eligible women for breast 
cancer and 6.5 % of those eligible for cervical cancer using federal funds [5, 6]. In addition, 
there was substantial variation across grantees, with screening proportions for NBCCEDP-
funded services varying from 1.6 to 52.8 % for breast cancer and 1.5 to 32.7 % for cervical 
cancer.
To date, no systematic assessment has been performed to understand the large variation in 
screening proportions across the funded programs. Identifying the factors that impact a 
grantee's ability to screen women in need will help to improve program operations to serve a 
larger proportion of eligible women. The Affordable Care Act is increasing access to 
insurance for millions of women, which provides coverage of breast and cervical cancer 
screening with no cost sharing. However, about half the states have not expanded Medicaid 
coverage under the law; therefore, a substantial number of low-income women will still 
likely be eligible for the screening services provided by the NBCCEDP [7]. In those states 
with Medicaid expansion, the NBCCEDP grantees will still provide screening services for 
those ineligible for insurance coverage and play an important role in referring low-income 
women for insurance coverage and in promoting and coordinating breast and cervical cancer 
screening and diagnostic services to ensure compliance with guideline recommendations.
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In this paper, we assess the importance of program- and state-level factors hypothesized to 
be associated with variation in screening proportions across the NBCCEDP grantees. The 
findings from this manuscript can be used to inform policies to improve screening 
proportions across the grantees.
Methods
We used data from the Current Population Survey Annual Social and Economic Supplement 
(CPS ASEC) for years 2006–2010 to estimate the number of women eligible for breast and 
cervical cancer screening through the NBCCEDP at the state level. Because the NBCCEDP 
only provides cervical cancer screening services to uninsured or underinsured low-income 
women with a cervix, we adjusted our estimates for hysterectomy status using information 
from the Behavioral Risk Factor Surveillance System (BRFSS). The number of women 
screened through the program was abstracted from the clinical data reported directly to CDC 
[Minimum Data Elements (MDE)] by each NBCCEDP grantee. We used data on the 
number of women eligible and number of women screened to calculate the proportion of 
eligible women screened through the NBCCEDP. The complete methods for calculating the 
screening proportions are described elsewhere [5, 6].
We used grantee- and program-level data collected using the NBCCEDP Cost Assessment 
Tool (CAT), such as average cost per women screened, to understand the factors that 
explain the variation in screening proportion across the grantees. We use the CAT which is a 
standardized web-based instrument designed to collect annual activity-based cost data from 
the grantees [8, 9]. It was designed to derive cost estimates from a programmatic 
perspective. A detailed protocol was used to guide the data collection at each site, and to 
ensure the accuracy of data collected with the CAT, a series of data quality checks were also 
performed. The CAT collected the proportion of cost spent on cervical versus breast cancer 
screening activities [8]. We were therefore able to separately derive the average cost per 
women for breast and cervical cancer screening.
The unit of analysis was the individual grantee rather than the client screened by the 
grantees as the objective of this study was to assess screening proportion variation across the 
NBCCEDP grantees. We constructed panel data using the three time periods of data 
collected for the CAT from each grantee (program-years July 2006–June 2007, July 2008–
June 2009, and July 2009–June 2010).
Study sample
We limited our sample to state-level programs and the District of Columbia (henceforth 
referred to as state programs) because screening proportions were not available for programs 
administered by tribes and territories (5 US territories and 11 American Indian/Alaska 
Native tribes). We also excluded state-level observations in which expenditures reported by 
the grantees in the CAT differed from funding levels reported to CDC by more than 10 % (n 
= 2 program). Finally, we excluded observations from one state which uses eligibility 
criteria that are dissimilar to the rest of the sample. The NBCCEDP funds 68 programs, and 
our final sample included 48 programs (144 program-year observations).
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The NBCCEDP proportion of women screened for breast and cervical cancer (for the same 
years as cost data above) were the dependent variables in this analysis. The screening 
proportion was defined as the number of women screened by each grantee using NBCCEDP 
funds divided by the number of women eligible for the program. The number of women 
screened was based on receipt of a NBCCEDP-funded cancer screening test within a 
recommended screening interval: mammogram within 2 years for breast screening and 
Papanicolaou (Pap) test within 3 years for cervical screening. These screening proportions 
excluded women who were screened by the grantees using other funding sources. The 
cohort of women used to derive the screening proportions were those eligible for the 
NBCCEDP if they met the specified age range (40–64 for breast cancer screening; 18–64 for 
cervical cancer screening); were uninsured; and had income at or less than 250 % of the 
federal poverty level (FPL). Some grantees implemented lower income thresholds for 
program eligibility. Overall, 31 grantees established income eligibility criteria at 250 % 
FPL, 17 at 200 %, two at 225 %, and one at 185 %.
Explanatory variables
The explanatory variables in this analysis include a set of program-specific variables and 
state-level factors that may influence the screening proportions. Program-specific variables 
were largely based on 3 years of cost data collected from the NBCCEDP grantees that 
received funding during the 2006–2010 fiscal years. Separate cost estimates were obtained 
for each time period, and the cost information was analyzed separately for breast and 
cervical cancer screens. The data were collected via the CAT which was developed for an 
economic evaluation of the NBCCEDP.
Program-specific variables include the average cost per women served, a measure of 
programmatic focus (proportion breast versus cervical cancer screens) and binary variables 
for screening delivery structure (centralized, decentralized, and mixed programs). We 
calculated the average cost per woman screened for breast and cervical cancer, respectively. 
This included the cost of screening and diagnostic evaluation and cost of program operations 
using cost data from the CAT and information on the number of women screened using 
federal funds from the MDE. Expenditures were divided into breast cancer-specific and 
cervical cancer-specific costs using relative allocations for each program activity reported in 
the CAT. We selected average cost per women screened and not total funding as an 
explanatory variable because past research has shown that NBCCEDP grantees have 
significant fixed cost related to program operations that are not directly related to the 
volume of women screened [10]. Because the screening proportions include only women 
who were screened using federal funds, these expenditures were limited to federal dollars by 
applying the percentage of total program funding that comes from the NBCCEDP. The 
average cost for each program-year observation was calculated by dividing federal 
expenditures allocated to breast and cervical cancer tests by the number of women screened 
for that cancer site. Average costs were analyzed on a log scale because of the heavily right-
skewed nature of the data. The proportion of women with breast and cervical cancer screens 
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were calculated based on information from the MDE (confirmed based on screens reported 
in the CAT). The number of women eligible for the NBCCEDP was obtained from CPS 
ASEC; this variable was included to assess whether the proportional volume of one type of 
cancer screening versus the other impacted the screening proportions achieved. Binary 
variables (three dummies for each type of structure) that indicate program screening delivery 
structure were constructed based on a series of self-reported indicators of program 
operations reported by the grantees in the CAT. Centralized programs hire their own staff 
and directly administer screening services, whereas decentralized programs contract out 
these services. Grantees with a mixed program structure share qualities from both of these 
classifications. We included this variable to determine whether the screening delivery 
structure had a significant influence on grantees’ ability to reach the eligible population.
Several state-level factors that were hypothesized to affect the grantee's ability to reach the 
eligible population were also included. First, the number of women in the specified age 
range and the fraction of this population that was eligible for the NBCCEDP were identified 
from the same data used to calculate the screening proportions [5, 6]. Second, the percentage 
of the population residing in urban areas was estimated using data from the Current 
Population Survey [11]. The proportion of women who were up to date with current 
recommendations for mammography (had test in the last 2 years) and Pap tests (had test in 
the last 3 years) was calculated using data from the BRFSS after applying appropriate 
exclusions (for instance, pregnant women and those who have undergone hysterectomies) 
[12]. The percentage of women with low access to medical care was estimated using the 
county-level Primary Care Health Professional Shortage Area designation from the 
Department of Health and Human Services. These data were obtained from the Area 
Resource File and were aggregated to the state level using county populations from the US 
Census as weights [13, 14]. We also included a time trend (year dummies) to control for any 
temporal factors that may affect the screening rates.
Statistical analysis
We analyzed NBCCEDP screening proportions using a random effects model. This 
specification was selected to account for correlation as we have included 3 years of data for 
each grantee. We analyzed breast and cervical cancer screening rates in separate regressions, 
using only independent variables that were relevant to that cancer site. The random effects 
regression was performed using Stata 12 [15]. We report the coefficient values, the 
confidence interval, and the p value.
Results
Table 1 presents the summary statistics for the dependent and explanatory variables. The 
mean screening proportions reported for the 2006–2010 period were 19.9 % (range = 2.2–
55.3 %) and 13.9 % (range = 2.2–44.6 %) for breast and cervical cancer screening, 
respectively. The average federal cost for delivering breast cancer screening was $316.43, 
and the average federal cost for cervical cancer screening was $196.70. Overall, 57.6 % of 
the women were screened for breast cancer, while 42.4 % were screened for cervical cancer. 
About half the programs were of mixed structure and another third were decentralized. In 
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general, there were wide variations across the state-level factors among the grantees (Table 
1). The proportion of women meeting program eligibility criteria for breast cancer screening 
ranged from 1.8 to 16.3 %, and for cervical cancer screening, the range was from 2.5 to 17.6 
%.
Tables 2 and 3 provide the results of the random effects regression to explain variation in 
breast and cervical cancer screening proportions, respectively. Overall, the models were able 
to explain about half of the variation in screening proportions for breast cancer (R2 = 0.49) 
and about a third of the variation in screening proportions for cervical cancer (R2 = 0.37). 
The program- and state-level variables that significantly impacted screening proportions 
were consistent across both models. Among the program-level variables, we found that 
average cost was significant and had a negative correlation with both breast and cervical 
cancer screening proportions. The other program variables (proportion of breast versus 
cervical screens and screening delivery structure) were not significant predictors of 
screening proportions. Among the state-level factors, the size of the state population, 
percentage of women eligible for the program, and the percentage of the population that 
resides in an urban area had a significantly negative effect on the screening proportions. 
State-specific measures of the proportion of women up to date with screening and the 
indicator for low access to care did not explain variation in screening. We also did not find a 
significant time trend for screening proportions over the time period analyzed.
In terms of magnitude, the results indicate that a 10 % increase in average cost was 
associated with a 0.49 % point decline [–5.13 × log (1.10) = –0.49 %] in screening 
proportions for breast cancer screening and a slightly lower decline of 0.41 [–4.27 × log 
(1.10) = –0.41] for cervical cancer screening. On the other hand, a 1 % point increase in the 
proportion of eligible women, conditional on the total number of women, was associated 
with lower screening proportions: by 1.68 and 0.81 % points for breast and cervical cancer 
screening, respectively. A 1 % point increase in the population residing in urban areas was 
associated with decreases in the screening proportion by 0.25 % points for breast cancer 
screens and about 0.17 % points for cervical cancer screens.
Discussion
The analysis of the factors impacting breast and cervical cancer screening proportions 
indicates that at least some of the variation among the grantees can be explained by 
program- and state-level characteristics included in the multivariate regressions performed. 
Most notably, grantees that serve larger populations, as measured by the size of the 
population and the percentage of women eligible for NBCCEDP services, tend to have 
lower screening proportions. Grantees whose populations were more concentrated in urban 
areas also tend to have lower screening proportions. In addition, higher average cost of 
women screened was associated with lower screening proportions.
Overall, volume of eligible women is the main driver of the differences seen in screening 
proportions across the states. Average cost of screening provision, which includes both 
clinical and programmatic cost, is also a factor. Recent economic analyses of the NBCCEDP 
have shown that substantial economies of scale exist in the program operations, and thus, 
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programs that serve larger populations tend to have lower average cost, that is, cost per 
women screened decreases as program size increases [10, 16]. Therefore, additional 
efficiencies could potentially be achieved if grantees collaborate on activities with 
substantial fixed costs (for example, database development/management or creation of 
patient educational materials). This could decrease the average cost of screening and in turn 
result in the ability to screen more women and thereby increase the proportion of eligible 
women served. Lower average cost will increase this proportion, but it will only have a 
modest impact; a 10 % decrease in cost will only result in about a half percentage point 
increase in the screening proportion. Regarding the finding of lower screening proportions 
among states with high concentrations of residents in urban areas, it is conceivable that hard-
to-reach populations, defined as those with low education, language barriers, and other 
factors associated with low socioeconomic status, reside in urban areas. Grantees may 
require additional resources to identify and inform hard-to-reach individuals using targeted 
education, outreach, and patient navigation services. It is also conceivable that constraints on 
program allocations that require or encourage funding to be spread throughout the state limit 
the ability of grantees to reach more women in densely populated urban areas. Additional 
research is needed to further explore this issue.
The analysis presented in this study benefited from detailed, activity-based cost data that 
were used to ascertain average cost per women served. In addition, a broad range of both 
program- and state-level characteristics were included in the multivariate assessment. 
Among the study limitations, the unit of analysis for this study was the state (and included 
DC) and not the grantee, as standardized estimates of eligible populations (used in 
calculating the screening proportions) were not available for NBCCEDP grantees that are 
tribal organizations and US territories. We also did not consider spatial structure including 
whether there were differences by regional clusters within states. In addition, we only 
included federal cost in this analysis and the screening proportions were restricted to women 
reached using federal funds. State programs may differ in how they use available non-
federal funds to reach their eligible population (for example, focus on urban versus rural 
areas), and therefore, assessment including all funds and screens in a given state may result 
in different findings from those presented in this study. Several NBCCEDP grantees pool 
funds from multiple sources to support their activities, and therefore, a direct correlation 
between program activity and funding stream may not always be possible [16]. Furthermore, 
we did not adjust for cost of providing services across states. Cost of living varies from state 
to state and could have an impact on the number of women screened. The study period was 
also during a major recession in the USA, and therefore, the pool of women eligible for 
NBCCEDP may have been much larger than generally expected. Also, we did include the 
average cost per women but not the details on the distribution of the cost which could differ 
across the programs due to variation in the cost of the tests and other services provided (such 
as patient navigation).
Overall, the average cost of screening, the overall size of the population eligible to be 
screened, and the concentration of population in urban areas all had a negative relationship 
to the proportion of eligible women screened by NBCCEDP grantees. These findings may 
be used to inform NBCCEDP grantees and help them identify ways to potentially implement 
program activities, reduce the cost of screening per woman, or make resource allocation 
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decisions that could result in serving a larger proportion of the NBCCEDP eligible 
population.
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Table 1
Summary statistics for program-and state-level variables (n = 144 program-years)
Mean SD Minimum Maximum
Screening proportion—breast (%) 19.94 12.03 2.22 55.29
Screening proportion—cervical (%) 13.89 10.42 2.23 44.58
Program-level factors
Federal average cost—breast ($)
a 316.43 155.13 75.36 1,089.63
Federal average cost—cervical ($)
a 196.70 145.68 41.95 1,509.93
Women served—breast (%) 57.61 8.70 33.65 79.33
Women served—cervical (%) 42.39 8.70 20.67 66.35
Screening program structure
    Centralized (%) 18.75
    Decentralized (%) 34.72 – – –
    Mixed (%) 46.53 – – –
State-level factors
Female state population 40–64 (millions) 1.02 1.09 0.08 5.80
Female state population 18–64 (millions) 1.91 2.09 0.16 11.36
Women aged 40–64 eligible for NBCCEDP 7.56 2.99 1.80 16.30
Women aged 18–64 eligible for NBCCEDP (%) 8.87 2.95 2.50 17.60
Population residing in urban area (%)
b 73.94 18.42 27.33 100.00
Up to date with mammography recommendations (%) 74.17 5.03 61.28 84.88
Up to date with Pap test recommendations (%) 82.28 3.70 71.44 89.81
Low access to care (%)
b 42.07 27.82 0.00 100.00
Time trend 2.65 1.22 1.00 4.00
a
Average cost per woman served
b
The 100 % reported in these categories are due to the inclusion of District of Columbia in the sample
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Table 2
Random effects regression model results for breast cancer screening proportion
Coefficient Lower CI Upper CI p Value
Log of federal average cost
a –5.13 –8.32 –1.93
0.002
***
Women served—breast (%) –0.01 –0.13 0.12 0.931
Screening program structure (compared to centralized)
    Decentralized 2.73 –4.45 9.91 0.456
    Mixed 4.73 –2.06 11.52 0.172
Female state population 40–64 (millions) –3.41 –6.09 –0.72
0.013
**
Women aged 40–64 eligible for NBCCEDP (%) –1.68 –2.22 –1.14
0.000
***
Population residing in urban area (%) –0.25 –0.40 –0.09
0.002
***
Mammogram compliance (%) 0.00 –0.33 0.33 0.985
Low access to care (%) 0.02 –0.07 0.10 0.704
Time trend 0.20 –0.30 0.70 0.433









Average cost per woman served
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Table 3
Random effects regression model results for cervical cancer screening proportion
Coefficient Lower CI Upper CI p Value
Log of federal average cost
a –4.27 –6.22 –2.31
0.000
***
Women served—cervical (%) 0.09 –0.02 0.19 0.100
Screening program structure (compared to centralized)
    Decentralized –1.70 –8.40 5.00 0.619
    Mixed –0.59 –6.96 5.79 0.857
Female state population 18–64 (millions) –1.54 –2.86 –0.22
0.023
**
Women aged 18–64 eligible for NBCCEDP (%) –0.81 –1.37 –0.25
0.004
***
Population residing in urban area (%) –0.17 –0.31 –0.02
0.022
**
Pap smear compliance (%) 0.07 –0.22 0.37 0.618
Low access to care (%) 0.01 –0.07 0.09 0.761
Time trend 0.01 –0.45 0.47 0.976









Average cost per woman served
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